1Yan De Kerkh of PCM.The psoniasis area and sevenity index and alternative approaches for the assessment of severity.Persisting areas of confusion.Br J Dermetol,1997,137:661.
2Brvan PP,Fred GW,Mark AG.Pathophysiology and trea-tmend of psoriasis.AM J Heaith-Syst Pham,2000,57:645.
1Christophers EL The immunopathology of psoriasis. Int Arch Allergy Immunol 1996; 110:199-206.
2Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999;20:40 - 46.
3Zepter K, Haffner A, Soohoo LF, et al. Induction of biologically active IL- 1beta - converting enzyme and mature IL- 1beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol 1997; 159:6203 - 6208.
4Delaporte E, Bieber T, Viac J, et al. Cytokines epidermique et inflammation cutanee.Ann Dermatol Venereol 1994; 121:836- 843.
5Psquer P, Pierard GE. Iterliukin - 6 and the skin. Int Arch Allergy Immunol 1996; 109:308 - 317.
7Lee RE, Gaspare AA, Lotze MT, et al. Interleukin2 and psoriasis. Arcb Dematol 1988;124:1811 - 1815.
8Fierlbeck G, Rasser G, Muller C. Psoriasis induced at the injection site of recmbenant interferon gamma. Arcb Dermatol Res 1990;126:351 - 355.
9Austin LM, Ozawa M, Kikuchi T, et al. The majority of epidermal T cell in psoriasis vulgaris lesions can produce type 1 cytokines, interferon - γ, interleukin- 2, and tumor necrosis factor - α, defining TC1 and TH1 effector populations: a type 1 differentiation bias in also measured in T cells in psoriatic patients.J Invest Dermatol 1999; 113:752- 759.
10Michel G, Mirmohammadsadegh A, Olasz E, et al. Demonstration and functional analysis of IL- 10 receptors in human epidermal cells: decreased expression in psoriation by an antipsoriatc gluccocorticoid in noomal cultured keratinocytes. J Immunol 1997; 159:6291 - 6297.
